Pknox1/Prep1 regulates mitochondrial oxidative phosphorylation components in skeletal muscle

Molecular and Cellular Biology

Volumn 34, Issue 2, 2014, Pages 290-298

  Kanzleiter, Timo ^a,e   Rath, Michaela ^a,e   Penkov, Dmitry ^b,c   Puchkov, Dmytro ^d   Schulz, Nadja ^a,e   Blasi, Francesco ^b   Schürmanna, Annette ^a,e  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^c MOSCOW STATE UNIVERSITY   (Russian Federation)

^d LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

^e GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A; CITRATE SYNTHASE; CITRIC ACID; CYTOCHROME C1; GENOMIC DNA; MESSENGER RNA; OXALOACETIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN; PROTEIN CONTENT FOR COMPLEX 1; PROTEIN P160; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SUCCINATE DEHYDROGENASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PREP1; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENERGY EXPENDITURE; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; MITOCHONDRIAL RESPIRATION; MOUSE; MUSCLE MITOCHONDRION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SKELETAL MUSCLE;

EID: 84891431835     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01232-13     Document Type: Article

References (25)

1. Ravussin E, Smith SR. 2002. Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann. N. Y. Acad. Sci. 967:363-378. http://dx.doi.org/10.1111/j.1749-6632.2002.tb04292.x.
2. Kraegen EW, Cooney GJ. 2008. Free fatty acids and skeletal muscle insulin resistance. Curr. Opin. Lipidol. 19:235-241. http://dx.doi.org/10.1097/01.mol.0000319118.44995.9a.
3. Chen H, Rossier C, Nakamura Y, Lynn A, Chakravarti A, Antonarakis SE. 1997. Cloning of a novel homeobox-containing gene, PKNOX1, and mapping to human chromosome 21q22.3. Genomics 41:193-200. http://dx.doi.org/10.1006/geno.1997.4632.
4. Berthelsen J, Viggiano L, Schulz H, Ferretti E, Consalez GG, Rocchi M, Blasi F. 1998. PKNOX1, a gene encoding PREP1, a new regulator of Pbx activity, maps on human chromosome 21q22.3 and murine chromosome 17B/C. Genomics 47:323-324. http://dx.doi.org/10.1006/geno.1997.5086.
5. Berthelsen J, Zappavigna V, Mavilio F, Blasi F. 1998. Prep1, a novel functional partner of Pbx proteins. EMBO J. 17:1423-1433. http://dx.doi.org/10.1093/emboj/17.5.1423.
6. Knoepfler PS, Calvo KR, Chen H, Antonarakis SE, Kamps MP. 1997. Meis1 and pKnox1 bind DNA cooperatively with Pbx1 utilizing an interaction surface disrupted in oncoprotein E2a-Pbx1. Proc. Natl. Acad. Sci. U. S. A. 94:14553-14558. http://dx.doi.org/10.1073/pnas.94.26.14553.
7. Penkov D, San Martín DM, Fernandez-Díaz LC, Rosselló CA, Torroja C, Sánchez-Cabo F, Warnatz HJ, Sultan M, Yaspo ML, Gabrieli A, Tkachuk V, Brendolan A, Blasi F, Torres M. 2013. Analysis of the DNA-binding profile and function of TALE homeoproteins reveals their specialization and specific interactions with Hox genes/proteins. Cell Rep. 3:1321-1333. http://dx.doi.org/10.1016/j.celrep.2013.03.029.
8. Ferretti E, Villaescusa JC, Di Rosa P, Fernandez-Diaz LC, Longobardi E, Mazzieri R, Miccio A, Micali N, Selleri L, Ferrari G, Blasi F. 2006. Hypomorphic mutation of the TALE gene Prep1 (pKnox1) causes a major reduction of Pbx and Meis proteins and a pleiotropic embryonic phenotype. Mol. Cell. Biol. 26:5650-5662. http://dx.doi.org/10.1128/MCB.00313-06.
9. Oriente F, Fernandez Diaz LC, Miele C, Iovino S, Mori S, Diaz VM, Troncone G, Cassese A, Formisano P, Blasi F, Beguinot F. 2008. Prep1 deficiency induces protection from diabetes and increased insulin sensitivity through a p160-mediated mechanism. Mol. Cell. Biol. 28:5634-5645. http://dx.doi.org/10.1128/MCB.00117-08.
10. Oriente F, Iovino S, Cabaro S, Cassese A, Longobardi E, Miele C, Ungaro P, Formisano P, Blasi F, Beguinot F. 2011. Prep1 controls insulin glucoregulatory function in liver by transcriptional targeting of SHP1 tyrosine phosphatase. Diabetes 60:138-147. http://dx.doi.org/10.2337/db10-0860.
11. National Institutes of Health. 2000. Public Health Service policy on humane care and use of laboratory animals. Office of Laboratory Animal Welfare, National Institutes of Health, Bethesda, MD.
12. Iotti G, Mejetta S, Modica L, Penkov D, Ponzoni M, Blasi F. 2012. Reduction of prep1 levels affects differentiation of normal and malignant B cells and accelerates myc driven lymphomagenesis. PLoS One 7:e48353. http://dx.doi.org/10.1371/journal.pone.0048353.
13. Schulz N, Himmelbauer H, Rath M, van Weeghel M, Houten S, Kulik W, Suhre K, Scherneck S, Vogel H, Kluge R, Wiedmer P, Joost H-G, Schürmann A. 2011. Role of medium- and short-chain L-3-hydroxyacyl-CoA dehydrogenase in the regulation of body weight and thermogenesis. Endocrinology 152:4641-4651. http://dx.doi.org/10.1210/en.2011-1547.
14. Brüning JC, Michael MD, Winnay JN, Hayashi T, Hörsch D, Accili D, Goodyear LJ, Kahn CR. 1998. A muscle-specific insulin receptor knock out exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell 2:559-569. http://dx.doi.org/10.1016/S1097-2765(00)80155-0.
15. Fan M, Rhee J, St-Pierre J, Handschin C, Puigserver P, Lin J, Jäeger S, Erdjument-Bromage H, Tempst P, Spiegelman BM. 2004. Suppression of mitochondrial respiration through recruitment of p160 myb binding protein to PGC-1alpha: modulation by p38 MAPK. Genes Dev. 18:278-289. http://dx.doi.org/10.1101/gad.1152204.
16. Díaz VM, Mori S, Longobardi E, Menendez G, Ferrai C, Keough RA, Bachi A, Blasi F. 2007. p160 Myb-binding protein interacts with Prep1 and inhibits its transcriptional activity. Mol. Cell. Biol. 27:7981-7990. http://dx.doi.org/10.1128/MCB.01290-07.
17. Andersen P, Saltin B. 1985. Maximal perfusion of skeletal muscle in man. J. Physiol. 366:233-249.
18. Holloszy J. 2009. Skeletal muscle "mitochondrial deficiency" does not mediate insulin. Am. J. Clin. Nutr. 89:463-466. http://dx.doi.org/10.1155/2012/768304.
19. Kelley DE, He J, Menshikova EV, Ritov VB. 2002. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51: 2944-2950. http://dx.doi.org/10.2337/diabetes.51.10.2944.
20. He J, Watkins S, Kelley DE. 2001. Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. Diabetes 50:817-823. http://dx.doi.org/10.2337/diabetes.50.4.817.
21. Lowell BB, Shulman GI. 2005. Mitochondrial dysfunction and type 2 diabetes. Science 307:384-387. http://dx.doi.org/10.1126/science.1104343.
22. Turner N, Heilbronn LK. 2008. Is mitochondrial dysfunction a cause of insulin resistance? Trends Endocrinol. Metab. 19:324-330. http://dx.doi.org/10.1016/j.tem.2008.08.001.
23. Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, Boss O, Michael LF, Puigserver P, Isotani E, Olson EN, Lowell BB, Bassel-Duby R, Spiegelman BM. 2002. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 418:797-801. http://dx.doi.org/10.1038/nature00904.
24. Scarpulla RC. 2008. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol. Rev. 88:611-638. http://dx.doi.org/10.1152/physrev.00025.2007.
25. Rowe GC, Patten IS, Zsengeller ZK, El-Khoury R, Okutsu M, Bampoh S, Koulisis N, Farrell C, Hirshman MF, Yan Z, Goodyear LJ, Rustin P, Arany Z. 2013. Disconnecting mitochondrial content from respiratory chain capacity in PGC-1-deficient skeletal muscle. Cell Rep. 3:1449-1456. http://dx.doi.org/10.1016/j.celrep.2013.04.023.